EverQuote operates an online marketplace for insurance shopping. Through its internet websites, the company operates an online marketplace for consumers shopping for auto, home and renters, life, health and commercial insurance. The company sells consumer referrals to insurance provider customers, consisting of carriers and agents, and indirect distributors.

FVCBankcorp is a bank holding company. Through its subsidiary, FVCbank, the company operates as a community oriented and managed commercial bank. The company provides a variety of lending products, including commercial real estate loans, commercial construction loans, commercial loans, SBA lending, asset based lending and accounts receivable financing, home equity loans, and consumer loans. The company also provides an array of deposit products, including interest and noninterest-bearing transaction accounts, certificates of deposit and money market accounts. Through third party networks, the company provides its customers access to a range of business insurance products and business and consumer credit card products.

Performant Financial provides echnology-enabled audit, recovery, outsource customer services, and related analytics services. The company's services help identify improper payments, and in some markets, restructure and recover delinquent or defaulted assets and improper payments. The company generally provides its services on an outsourced basis, where the company handles various aspects of its clients' recovery processes. The company uses its technology-enabled services platform to provide recovery and analytics services in a range of markets for the identification and recovery of student loans, improper healthcare payments and delinquent state and federal tax and federal treasury receivables.

Quanex Building Products manufactures components for original equipment manufacturers in the building products industry. The company's segments are: North American Fenestration, which focuses on the fenestration market in North America manufacturing vinyl profiles, insulating glass (IG) spacers, screens and other fenestration components; European Fenestration, comprising the company's United Kingdom-based vinyl extrusion business, manufacturing vinyl profiles and conservatories, and the European IG business manufacturing IG spacers; and North American Cabinet Components, comprising the company's North American cabinet door and components business and wood-manufacturing plants.

Stitch Fix provides apparel, shoes, and accessories across categories, brands, product types, and price points. The company serves its clients in the following categories: Women's, Petite, Maternity, Men's, Plus, and Kids. The company carries a mix of third-party branded merchandise, including brands, and its own Exclusive Brands. The company also provides a variety of product types, including denim, dresses, blouses, skirts, shoes, jewelry, and handbags. The company combines data science and human judgment to deliver one-to-one personalization to its clients at scale. The company helps its clients discover and buy what they love through data-driven, personalized, hand-selected shipments of apparel, shoes, and accessories.

Thor Industries is a manufacturer of recreational vehicles. The company has three segments: North American Towable Recreational Vehicles, which consists of: Airstream (towable), Heartland (including Bison, Cruiser RV and DRV), Jayco (including Jayco towable, Starcraft and Highland Ridge), Keystone (including CrossRoads and Dutchmen) and KZ (including Venture RV); North American Motorized Recreational Vehicle, which consists of: Airstream (motorized), Jayco (including Jayco motorized and Entegra Coach) and Thor Motor Coach; and European Recreational Vehicles, which consists of the Erwin Hymer Group business.

TRACON Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of targeted therapeutics for cancer and wet age-related macular degeneration. The company is developing its primary product candidate, TRC105 (carotuximab), an endoglin antibody, for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor pathway, or in combination with inhibitors of the programmed cell death protein 1 pathway. The company's second clinical stage product oncology candidate is TRC102, a small molecule being developed for the treatment of lung cancer and mesothelioma.